RANDOMIZED TRIAL IN ADVANCED OVARIAN-CANCER COMPARING CISPLATIN AND CARBOPLATIN

被引：146

作者：

MANGIONI, C

BOLIS, G

PECORELLI, S

BRAGMAN, K

EPIS, A

FAVALLI, G

GAMBINO, A

LANDONI, F

PRESTI, M

TORRI, W

VASSENA, L

ZANABONI, F

MARSONI, S

机构：

[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY

[2] UNIV MILAN,OSPED S GERARDO,OSTETTR GINECOL CLIN,I-20122 MILAN,ITALY

[3] UNIV MILAN,OSTET GINECOL CLIN 3,I-20122 MILAN,ITALY

[4] UNIV BRESCIA,OSTET GINECOL CLIN,BRESCIA,ITALY

[5] BRISTOL MYERS,PHARMACEUT RES & DEV,BRUSSELS,BELGIUM

来源：

关键词：

D O I：

10.1093/jnci/81.19.1464

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1464 / 1471

页数：8

共 32 条

[1] HIGH-DOSE PLATINUM FOR THE TREATMENT OF REFRACTORY OVARIAN-CANCER
BRUCKNER, HW
WALLACH, R
COHEN, CJ
DEPPE, G
KABAKOW, B
RATNER, L
HOLLAND, JF
[J]. GYNECOLOGIC ONCOLOGY, 1981, 12 (01) : 64 - 67
[2] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II
CALVERT, AH
HARLAND, SJ
NEWELL, DR
SIDDIK, ZH
JONES, AC
MCELWAIN, TJ
RAJU, S
WILTSHAW, E
SMITH, IE
BAKER, JM
PECKHAM, MJ
HARRAP, KR
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 140 - 147
[3] CONTE PF, 1987, P ASCO, V6, P118
[4] COX DR, 1972, J R STAT SOC B, V34, P187
[5] COX DR, 1970, ANAL BINARY DATA, P18
[6] EDMONSON JH, 1988, P AN M AM SOC CLIN, V7, P137
[7] EISENHAUER EA, 1986, CANCER TREAT REP, V70, P1195
[8] EVANS BD, 1983, CANCER TREAT REP, V67, P997
[9] GORE ME, 1987, P ASCO, V6, P117
[10] Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4